| Term 
 | Definition 
 
        | binds a nuclear receptor that stimulates the production of Na-K-ATPases in the distal tubule/collecting ducts Increases: water, sodium
 Decreases: potassium
 |  | 
        |  | 
        
        | Term 
 
        | Anti-diuretic hormone 
 (ADH)(vasopressin)
 |  | Definition 
 
        | binds a membrane receptor and through a GPCR-cAMP pathway causes the phosphorylation of aquaporin channels that are inserted in the late tubule/collecting ducts Increases: water
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NKCC2 moves Na K Cl into cells and K leaks back out which builds up a positive charge and drives Ca reabsorbtion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - carbonic anhydrase inhibitor MOA - inhibits CA which normally converts bicarb/H+ to H2O/CO2
 where: proximal tubule, eyes
 Decreases: water, bicarb, sodium, potassium
 Decreases: GFR, renin, and BP
 Tx - glaucoma
 AE - acidosis, kidney stones (nephrolithiasis), low K+
 |  | 
        |  | 
        
        | Term 
 
        | hydrochlorothiazide 
 (Esidrex)
 |  | Definition 
 
        | class - thiazide diuretic MOA - inhibits Na-Cl cotransporter (NCC) which normally reabsorbs these salts
 where: distal convoluted tubule
 Increases: calcium
 Decreases: water, sodium, potassium
 AE - hyopkalemia, gout, increased lipids
 X - NSAIDS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - loop diuretic MOA - inhibits Na-K-Cl cotransporter (NKCC2) which normally reabsorbs these salts
 where: thick ascending limb in the Loop of Henle
 Increases: GFR (prostaglandins/macula densa)
 Decreases: water, sodium, potassium, calcium
 AE - hypokalemia, gout, ototoxicity (balance/hearing loss)
 X - NSAIDS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - potassium sparing diuretic MOA - inhibits Na channel (ENaC) which normally reabsorbs Na
 where: late tubule/collecting duct
 Increases: potassium, H+
 Decreases: water, sodium
 AE - hyperkalemia, acidosis
 |  | 
        |  | 
        
        | Term 
 
        | spironolactone 
 (Aldactone)
 |  | Definition 
 
        | class - aldosterone antagonist MOA - blocks the action of aldosterone which normally increases H2O/Na and decreases K
 *works on capillary side unlike the previous drugs
 where: collecting tubule (principal cells)
 Increases: potassium
 Decreases: water, sodium
 AE - hyperkalemia, acidosis, gynecomastia (breast), hirsutism (hair)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - ACE inhibitor MOA - inhibits ACE which normally converts Ang1 to Ang2 (a vasopressor)
 *note: alternate pathways exist to still produce Ang2
 Increases: bradykinin, PG/renin
 Decreases: aldosterone
 AE - orthostatic HTN, hyperkalemia, cough
 X - pregnancy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - angiotensin receptor blocker MOA - inhibit AT1 receptors which normally bind Ang2 and cause vasoconstriction
 Decreases: aldosterone
 AE - orthostatic HTN, hyperkalemia
 X - pregnancy
 NOTE - ARBs reduce the activation of AT1 receptors more effectively than ACEIs
 NOTE - ARBs allow activation of AT2 receptors (vasodilate)
 |  | 
        |  |